MC
BIO icon

Machina Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Machina Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-618
Closed -$348K – 127
2022
Q1 		$348K Buy
+618
New +$373K 0.76% 51
2020
Q1 		– Sell
-1,160
Closed -$429K – 39
2019
Q4 		$429K Buy
1,160
+80
+7% +$28.2K 0.17% 209
2019
Q3 		$359K Buy
1,080
+136
+14% +$44.4K 0.16% 195
2019
Q2 		$295K Buy
944
+357
+61% +$107K 0.11% 214
2019
Q1 		$179K Buy
+587
New +$158K 0.07% 243

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Machina Capital's BIO Position: Q2 2022 in Review

Machina Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2022, closing a stake of 618 shares — an estimated $348K sold.

Machina Capital first reported a position in BIO in Q1 2019 and held it in 5 quarters. The position peaked at $429K in Q4 2019. 500 funds tracked by Wall St. Rank hold BIO as of Q2 2022.

  • Machina Capital reported no remaining Bio-Rad Laboratories Class A position as of Q2 2022 after selling out during the quarter.
  • Machina Capital sold 618 Bio-Rad Laboratories Class A shares in Q2 2022, an estimated $348K.
  • Machina Capital first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 5 quarters.
  • Machina Capital's Bio-Rad Laboratories Class A position peaked at $429K in Q4 2019.
  • 500 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2022.

Based on Machina Capital's 13F filing for Q2 2022, filed 8 Aug 2022.